brand logo

Am Fam Physician. 2013;87(6):444

Clinical Question

Do daily multivitamin supplements reduce the risk of cancer and subsequent morbidity/mortality in adult men?

Bottom Line

Daily multivitamin supplementation results in a minimal, if any, reduction in epithelial cell cancers in men. This study found no significant benefit to multivitamin supplementation in reducing the risk of prostate, colorectal, lung, or bladder cancers. The risks of cancer-related mortality and all-cause mortality were also not reduced by multivitamin supplementation. (Level of Evidence = 1b –)


GazianoJMSessoHDChristenWGet alMultivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA.2012; 308( 18): 1871– 1880.

Study design: Randomized controlled trial (double-blinded)

Funding source: Government

Allocation: Uncertain

Setting: Population-based


As part of the Physicians' Health Study—which evaluated various health interventions including aspirin, vitamin E, and beta carotene—these investigators analyzed separate data on the potential value of daily multi-vitamin supplements on cancer prevention. Eligible men (n = 14,641) 50 years or older randomly received (uncertain allocation concealment) a common daily multivitamin supplement (Centrum Silver) or matched placebo. Of these, 5.1 and 9.0 percent had a history of cardiovascular disease and cancer, respectively. Approximately 40 percent were former smokers, and 3.6 percent were current smokers. Individuals masked to treatment group assignment assessed outcomes, including all cancer and mortality end points. Complete follow-up occurred for more than 98 percent of participants for a median of 11.2 years.

Using intention-to-treat analysis, the authors report a significant reduction in the incidence of total cancer cases in men taking a daily multivitamin compared with those taking placebo (17.0 versus 18.3 events, respectively, per 1,000 person-years). However, I used a validated statistical tool to calculate the number needed to treat and the 95% confidence interval using the actual number of cases among patients in each treatment group, and the difference was not statistically significant. The authors note that their analysis was adjusted, and thus resulted in statistical significance. (Without that adjustment, would this paper have been published in JAMA?) If the result as reported was significant, the number needed to treat would be 83 for 11.2 years. Only the number of epithelial cell cancers was significantly lower among individuals taking daily multivitamin supplements; there were no significant differences in prostate, colorectal, lung, or bladder cancers between the treatment group and the control group. There was also no significant difference in cancer-related mortality or all-cause mortality. Results were similar for patients with a history of cancer.

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2013 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.